New-Onset Hyperglycemia and Acute Coronary Syndrome: A Systematic Overview and Meta-Analysis
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Patients without a history of diabetes often develop hyperglycemia during an acute coronary syndrome (ACS). New onset of hyperglycemia (NH) is associated with higher mortality both in the short and long-term. AIM: We performed a systematic review and meta-analysis of observational studies to investigate the association between NH and mortality in patients with ACS. In-hospital, 30-day and long-term mortality were analyzed separately. METHODS: We searched MEDLINE for prospective studies of patients with ACS reporting the association between NH and mortality, using Research Methodology Filters. This was supplemented by hand searching reference lists of retrieved articles. We determined study eligibility and conducted data abstraction independently and disagreements were resolved by consensus. We pooled odds ratios (OR) from individual studies using a random effects model. RESULTS: Our search strategy identified 24 studies. The prevalence of NH varied widely 3% to 71% depending on the definition of NH used. NH significantly increased the risk of in-hospital (OR 3.62, 95% CI: 3.09 - 4.24; p < 0.0001, I2=0.0%; 15 studies, 10673 patients), 30-day (OR 4.81, 95% CI: 2.18 - 10.61, p < 0.0001, I2=92.2%; 4 studies, 101447 patients), and long-term (up to 108 months) mortality (OR 2.02, 95% CI: 1.62-2.51; p < 0.0001, I2=79.4%; 12 studies, 102099 patients). CONCLUSIONS: In patients without a prior diagnosis of diabetes who are admitted to hospital for ACS, NH increases the risk of both short and long-term mortality. These data highlight the need for further studies addressing the control of blood glucose levels in patients with ACS. SUMMARY: Patients without history of diabetes may develop new hyperglycemia (NH) on admission to hospital for AMI. We systematically reviewed the prognostic impact of NH on short- and long-term mortality in patients without prior diagnosis of diabetes who attended the hospital for ACS. We identified 24 outcome studies which met a set of pre-specified criteria. Prevalence of NH ranged from 3% to 71% according to different thresholds of blood glucose concentrations. NH significantly increased the risk of in-hospital (OR 3.62, 95% CI: 3.09 - 4.24; p < 0.0001, I2=0.0%; 15 studies, 10673 patients), 30-day (OR 4.81, 95% CI: 2.18 - 10.61, p < 0.0001, I2=92.2%; 4 studies, 101447 patients)), and long-term (up to 108 months) mortality (OR 2.02, 95% CI: 1.62-2.51; p < 0.0001, I2=79.4%; 12 studies, 102,099 patients).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mortality correlates more strongly to the blood glucose level than to the presence of diabetes.419,420”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [420]
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · cited 2×
“Typically, values above 50% are deemed to suggest large between-study heterogeneity, values of 25–50% are deemed to show modest heterogeneity, and values below 25% denote low heterogeneity [7].”
BackgroundMethodIntensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119 · cited 2×
“In the recent Normoglycemia in Intensive Care Evaluation–Survival Using Glucose Algorithm Regulation (NICESUGAR) study on intensive insulin therapy [48], a tight glucose control (4.”
MethodHow should meta‐regression analyses be undertaken and interpreted?
Thompson, S. G., & Higgins, J. P. T. (2002) · Statistics in Medicine · doi:10.1002/sim.1187 · Cited by 3,026 · cited 2×
“This method uses each study’s estimate and its standard error to separate within-study from between-study variability [10].”
MethodCapes, S. E., Hunt, D., Malmberg, K., & Gerstein, H. C. (2000) · The Lancet · doi:10.1016/s0140-6736(99)08415-9 · Cited by 2,187 · cited 1×
“[35].”
(2000) · Queen Mary Research Online (Queen Mary University of London) · Cited by 1,795
Malmberg, K. (1997) · BMJ · doi:10.1136/bmj.314.7093.1512 · Cited by 1,286
Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus
Buse, J. B., Ginsberg, H. N., Bakris, G. L., Clark, N. G., Costa, F., Eckel, R., Fonseca, V., Gerstein, H. C., Grundy, S., Nesto, R. W., et al. (2007) · Diabetes Care · doi:10.2337/dc07-9917 · Cited by 1,055 · cited 1×
“Diabetic patients have a 2-to-4 times higher coronary artery disease (CAD) or stroke death rate [1, 2].”
BackgroundMalmberg, K., Rydén, L., Wedel, H., Birkeland, K., Bootsma, A., Dickstein, K., Efendic, S., Fisher, M., Hamsten, A., Herlitz, J., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi199 · Cited by 1,048
Malmberg, K., Norhammar, A., Wedel, H., & Rydén, L. (1999) · Circulation · doi:10.1161/01.cir.99.20.2626 · Cited by 847
Developing Optimal Search Strategies for Detecting Clinically Sound Studies in MEDLINE
Haynes, R. B., Wilczynski, N., McKibbon, K. A., Walker, C. J., & Sinclair, J. C. (1994) · Journal of the American Medical Informatics Association · doi:10.1136/jamia.1994.95153434 · Cited by 765 · cited 1×
“We searched for eligible studies, using research Methodology Filters (see appendix) [5].”
MethodKosiborod, M., Rathore, S. S., Inzucchi, S. E., Masoudi, F. A., Wang, Y., Havranek, E. P., & Krumholz, H. M. (2005) · Circulation · doi:10.1161/circulationaha.104.517839 · Cited by 666 · cited 7×
“A recent analysis of the Cooperative Cardiovascular Project (CCP) which included a large cohort of elderly patients (n=141680) with ACS [12] showed that depending on different levels of glucose on admission ( 110, 110 to 140, 140 to 170, 170 to 240 and 240 mg/dL), NH was associated with a”
BackgroundInfluentialThe CREATE-ECLA Trial Group Investigators* (2005) · JAMA · doi:10.1001/jama.293.4.437 · Cited by 641
BARTNIK, M. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.07.027 · Cited by 617 · cited 1×
“The Euro Heart Survey on Diabetes and the Heart [4] analyzed the prevalence of abnormal glucose metabolism in patients with acute coronary”
BackgroundDeedwania, P., Kosiborod, M., Barrett, E., Ceriello, A., Isley, W., Mazzone, T., & Raskin, P. (2008) · Circulation · doi:10.1161/circulationaha.107.188629 · Cited by 488 · cited 6×
“Recently, a joint scientific statement of the American Heart Association (AHA) and American Diabetes Association (ADA) reviewed the prognostic impact of NH during hospitalization for MI [3].”
BackgroundInfluentialMorigi, M., Angioletti, S., Imberti, B., Donadelli, R., Micheletti, G., Figliuzzi, M., Remuzzi, A., Zoja, C., & Remuzzi, G. (1998) · Journal of Clinical Investigation · doi:10.1172/jci656 · Cited by 438 · cited 2×
“For instance, it has been shown that hyperglycemia increases platelet aggregation [36], impairs coronary endothelial function and increases the release of inflammatory and vasoconstrictive factors [37, 38].”
BackgroundBell, D. S. H. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2433 · Cited by 404 · cited 1×
“Diabetic patients have a 2-to-4 times higher coronary artery disease (CAD) or stroke death rate [1, 2].”
BackgroundWahab, N. N., Cowden, E. A., Pearce, N. J., Gardner, M. J., Merry, H., & Cox, J. L. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02483-x · Cited by 393 · cited 5×
“15 studies [11, 13-26] examined the prognostic impact of NH on in-hospital mortality for a total of 10673 patients and 909 deaths.”
BackgroundInfluentialStranders, I., Diamant, M., van Gelder, R. E., Spruijt, H. J., Twisk, J. W. R., Heine, R. J., & Visser, F. C. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.9.982 · Cited by 353 · cited 5×
“15 studies [11, 13-26] examined the prognostic impact of NH on in-hospital mortality for a total of 10673 patients and 909 deaths.”
BackgroundInfluentialOswald, G. A., Smith, C. C., Betteridge, D. J., & Yudkin, J. S. (1986) · BMJ · doi:10.1136/bmj.293.6552.917 · Cited by 265 · cited 3×
“The final search leaved 24 studies [11-34] that fulfilled all our inclusion criteria.”
BackgroundSuleiman, M., Hammerman, H., Boulos, M., Kapeliovich, M. R., Suleiman, A., Agmon, Y., Markiewicz, W., & Aronson, D. (2005) · Circulation · doi:10.1161/01.cir.0000155235.48601.2a · Cited by 245 · cited 3×
“The final search leaved 24 studies [11-34] that fulfilled all our inclusion criteria.”
BackgroundAguilar, D., Solomon, S. D., Køber, L., Rouleau, J.-L., Skali, H., McMurray, J. J. V., Francis, G. S., Henis, M., O’Connor, C. M., Diaz, R., et al. (2004) · Circulation · doi:10.1161/01.cir.0000142047.28024.f2 · Cited by 230 · cited 3×
“VALIANT [30] ACS”
BackgroundWorthley, M. I., Holmes, A. S., Willoughby, S. R., Kucia, A. M., Heresztyn, T., Stewart, S., Chirkov, Y. Y., Zeitz, C. J., & Horowitz, J. D. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.053 · Cited by 187 · cited 1×
“For instance, it has been shown that hyperglycemia increases platelet aggregation [36], impairs coronary endothelial function and increases the release of inflammatory and vasoconstrictive factors [37, 38].”
BackgroundHyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus
Bellodi, G., Manicardi, V., Malavasi, V., Veneri, L., Bernini, G., Bpssini, P., Distefano, S., Magnanini, G., Muratori, L., Rossi, G., et al. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90836-9 · Cited by 160
Ishihara, M., Kagawa, E., Inoue, I., Kawagoe, T., Shimatani, Y., Kurisu, S., Nakama, Y., Maruhashi, T., Ookawa, K., Dai, K., et al. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.01.044 · Cited by 137 · cited 4×
“The final search leaved 24 studies [11-34] that fulfilled all our inclusion criteria.”
BackgroundInfluentialIn-Hospital Prognosis of Ppatients With Fasting Hyperglycemia After First Myocardial Infarction
O'Sullivan, J. J., Conroy, R. M., Robinson, K., Hickey, N., & Mulcahy, R. (1991) · Diabetes Care · doi:10.2337/diacare.14.8.758 · Cited by 106
Metabolic causes and prevention of ventricular fibrillation during acute coronary syndromes
Oliver, M. F. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)01104-4 · Cited by 91
Meisinger, C., Hörmann, A., Heier, M., Kuch, B., & Löwel, H. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.11.018 · Cited by 83 · cited 3×
“The final search leaved 24 studies [11-34] that fulfilled all our inclusion criteria.”
BackgroundPinto, D. S., Kirtane, A. J., Pride, Y. B., Murphy, S. A., Sabatine, M. S., Cannon, C. P., & Gibson, C. M. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.08.034 · Cited by 82
Admission glycaemia and outcome after acute coronary syndrome
Pétursson, P., Herlitz, J. D., Caidahl, K., Guðbjörnsdóttir, S., Karlsson, T., Perers, E., Sjöland, H., & Hartford, M. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.04.043 · Cited by 76 · cited 4×
“The final search leaved 24 studies [11-34] that fulfilled all our inclusion criteria.”
BackgroundInfluentialAinla, T., Baburin, A., Teesalu, R., & Rahu, M. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01625.x · Cited by 75 · cited 3×
“The final search leaved 24 studies [11-34] that fulfilled all our inclusion criteria.”
BackgroundRay, K. K., Cannon, C. P., Morrow, D. A., Kirtane, A. J., Buros, J., Rifai, N., McCabe, C. H., Gibson, C. M., & Braunwald, E. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm010 · Cited by 69 · cited 2×
“For instance, it has been shown that hyperglycemia increases platelet aggregation [36], impairs coronary endothelial function and increases the release of inflammatory and vasoconstrictive factors [37, 38].”
Background(1989) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068339 · Cited by 55 · cited 3×
“The final search leaved 24 studies [11-34] that fulfilled all our inclusion criteria.”
BackgroundSchiele, F., Descotes‐Genon, V., Seronde, M., Blonde, M., Legalery, P., Meneveau, N. F., Ecarnot, F., Mercier, M., Penfornis, A., Thebault, L., et al. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.02000.x · Cited by 45 · cited 4×
“The final search leaved 24 studies [11-34] that fulfilled all our inclusion criteria.”
BackgroundInfluentialValue of Glycosylated Hemoglobin Measurements After Acute Myocardial Infarction
Soler, N. G. (1981) · JAMA · doi:10.1001/jama.1981.03320150038026 · Cited by 41 · cited 3×
“Soler [15] ACS 1981 ns 6.”
BackgroundNordin, C., Amiruddin, R., Rucker, L., Choi, J., Kohli, A., & Marantz, P. R. (2005) · Cardiology in Review · doi:10.1097/01.crd.0000137251.77175.6a · Cited by 38 · cited 5×
“15 studies [11, 13-26] examined the prognostic impact of NH on in-hospital mortality for a total of 10673 patients and 909 deaths.”
BackgroundInfluentialGąsior, M., Pres, D., Stasik-Pres, G., Lech, P., Gierlotka, M. J., Hawranek, M., Wilczek, K. L., Szyguła‐Jurkiewicz, B., Lekston, A., Kalarus, Z. F., et al. (2008) · PubMed · Cited by 38
Hyperglycemia During Acute Myocardial Infarction
Ravid, M. (1975) · JAMA · doi:10.1001/jama.1975.03260070065026 · Cited by 37 · cited 3×
“The final search leaved 24 studies [11-34] that fulfilled all our inclusion criteria.”
BackgroundEffect of Hyperglycemia and Insulin in Acute Coronary Syndromes
Dandona, P., Chaudhuri, A., Ghanim, H., & Mohanty, P. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.04.004 · Cited by 31 · cited 1×
“However, despite good experimental evidence that treatment with insulin reduces inflammation and improves endothelial function and fibrinolysis in patients with ACS [42, 43], the clinical benefits of an aggressive treatment with insulin are yet unproven.”
BackgroundGoldberg, R. J., Kramer, D. G., Lessard, D., Yarzebski, J., & Gore, J. M. (2007) · Coronary Artery Disease · doi:10.1097/01.mca.0000236291.79306.98 · Cited by 19 · cited 3×
“The final search leaved 24 studies [11-34] that fulfilled all our inclusion criteria.”
BackgroundThe influence of admission glucose on epicardial and microvascular flow after primary angioplasty
Shen, X., Jia, S.-Q., & Li, H. (2006) · Chinese Medical Journal · doi:10.1097/00029330-200601020-00002 · Cited by 16 · cited 3×
“The final search leaved 24 studies [11-34] that fulfilled all our inclusion criteria.”
BackgroundEstimating the Treatment Difference in an Individual Trial
Whitehead, A. (2002) · doi:10.1002/0470854200.ch3 · Cited by 11 · cited 2×
“A continuity correction was used for trials without events in one arm [6].”
MethodScott, A. R., Cheng, A., Greenacre, M. J., & Devlin, G. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00597.x · Cited by 11 · cited 3×
“The final search leaved 24 studies [11-34] that fulfilled all our inclusion criteria.”
BackgroundIijima, R., Nakajima, R., Sugi, K., & Nakamura, M. (2007) · Circulation Journal · doi:10.1253/circj.71.1079 · Cited by 9
Lewandowicz, J., Jm, K., & Goźliński, H. (1979) · PubMed · Cited by 6
Cited by
2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Swaddling and the Risk of Sudden Infant Death Syndrome: A Meta-analysis
Pease, A. S., Fleming, P. J., Hauck, F. R., Moon, R. Y., Horne, R. S. C., L’Hoir, M. P., Ponsonby, A.-L., & Blair, P. S. (2016) · Pediatrics · doi:10.1542/peds.2015-3275 · Cited by 161
Hyperglycemia in acute coronary syndromes: from mechanisms to prognostic implications
Angeli, F., Reboldi, G., Poltronieri, C., Lazzari, L., Sordi, M., Garofoli, M., Bartolini, C., & Verdecchia, P. (2015) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944715594528 · Cited by 98
“Regardless of its classification, prevalence of hyperglycemia in different epidemiological studies (Table 1) ranges from 3% to 71% of patients admitted with ACS [Angeli et al. 2010, 2013].”
BackgroundMethodResultInfluentialSelf-citationZuo, Y.-Y., Kang, Y., Yin, W., Wang, B., & Chen, Y. (2012) · Journal of Critical Care · doi:10.1016/j.jcrc.2011.12.004 · Cited by 38
Ye, Y., Xie, H., Zhao, X., & Zhang, S. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-155 · Cited by 27
“Introduction Numerous studies have demonstrated that hyperglycemia is common among patients with acute coronary syndrome (ACS) [1,2], and the relationship between hyperglycemia and increased mortality risk in ACS has been well established across various glucose metrics [3,4].”
Background
Metadata
- Authors
- Angeli, F., Verdecchia, P., Karthikeyan, G., Mazzotta, G., Pinto, M., Repaci, S., Gatteschi, C., Gentile, G., Cavallini, C., & Reboldi, G.
- Corresponding author
- Verdecchia, Paolo
- Reboldi, Gianpaolo
- ORCID
- Venue
- Current Diabetes Reviews
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2010-03-01
- Volume
- 6
- Issue
- 2
- Pages
- 102-110
- ISSN
- 1573-3998 (ISSN-L)
- OpenAlex
- W2114325741
- Cited by
- 48
- References
- 44
- Citations by year
- 2025: 2 · 2023: 6 · 2022: 3 · 2020: 3 · 2018: 3 · 2017: 3 · 2016: 5 · 2015: 3 · 2014: 4 · 2013: 6 · 2012: 4
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Diabetes Reviews (publishedVersion)
- PubMed (publishedVersion)
- IrInSubria (University of Insubria) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- acute coronary syndrome, mortality, in-hospital mortality, 30-day mortality, long-term mortality, non-diabetic patients, glycemic control, myocardial infarction, prognostic factors
- MeSH terms
- Adult, Aged, Aged, 80 and over, Blood Glucose, Humans, Hyperglycemia, Patient Admission, Prognosis, Hospital Mortality, Diabetes Complications, Acute Coronary Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.